Position in FTRE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$38,710,548
-$32,202,459 QoQ
Shares Held
4,109,400
-0.0% QoQ
Ownership
4.34%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 26.836740156713873.ToString("F0")%
Shared 0.017034116902710856.ToString("F0")%
None 73.14622572638342.ToString("F0")%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,287,966,567 across 421 Biotechnology names. FTRE ranks #109 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in FTRE
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $38,710,548 | 4,109,400 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $70,913,007 | 4,110,899 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $34,278,847 | 4,071,122 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $21,894,880 | 4,432,162 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $24,637,424 | 3,263,235 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $62,871,164 | 3,371,108 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $65,013,860 | 3,250,693 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $70,419,487 | 3,017,116 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $125,991,632 | 3,138,805 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $100,444,398 | 2,878,063 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $80,129,850 | 2,802,723 | Shares | Defined | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||